Want to join the conversation?
$STE expects total revenue growth in the range of 22-23% for FY17, including about 6% organic revenue growth, down from prior outlook of 25-26% revenue growth and about 7% organic growth. The company continues to expect $15MM in cost synergies as a result of the combination with Synergy and an adjusted effective tax rate of approx. 25% in FY17.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.